Units / BMS5007
BMS5007 · Biotechnology: Commercialising biomedical science
2026 Handbook6 credit pointsLevel 5School of Biomedical Sciences
Last checked: 23 Aug 2026 UTCOverview
This unit will examine case studies of medical biotechnology research and development, and will consider the industry context in which biotechnology is commercialised including: industry structure and competition; methods of financing, management approaches; the regulatory environment; product development and its commercial protection via intellectual property; and taking the product to market. You will examine case studies to analyse and evaluate the chances of commercialisation success of Australian companies in various phases of development, and present and justify their opinions in the form of class discussions, oral presentations and written business reports.
Offerings
| Campus | Teaching period | Mode |
|---|---|---|
| Clayton | First semester | Teaching activities are on-campus (ON-CAMPUS) |
| Clayton | Second semester | Teaching activities are on-campus (ON-CAMPUS) |
| Suzhou (SEU) | First semester | Teaching activities are on-campus (ON-CAMPUS) |
Assessment
The Handbook does not list a final examination among the assessment items. That is not a guarantee there is none.
| # | Assessment | Type | Weight | Hurdle |
|---|---|---|---|---|
| 1 | 2 x Case study reports (4,500 words total) | Demonstration | 55% | — |
| 2 | In-class worksheets (1000 words) | Exercise | 30% | — |
| 3 | Group oral presentation (15 minutes per group) | Presentation | 10% | — |
| 4 | Participation in workshop / class discussions | Exercise | 5% | — |
Assessment details may change. Please refer to the assessment information in Moodle closer to the start of the teaching period.
Requisites
The Handbook lists no prerequisite, corequisite or prohibition for this unit.
Learning outcomes
- Interpret and critically evaluate the pathways from discovery science that lead to innovation and commercialisation of biotechnology innovations;
- Analyse and evaluate the critical role of intellectual property in the commercialisation of biotechnology;
- Apply advanced knowledge of how the major regulatory bodies [e.g. TGA (Therapeutic Goods Administration); FDA (Food & Drug Administration); CTN (Clinical Trial Notification Scheme)] deal with specific innovations in the biotech / medtech sectors;
- Evaluate and critically assess and predict the potential for commercial development and success of a specific biotechnology innovation;
- Systematically build and validate arguments and opinions by sourcing and critically deconstructing relevant material and information, working both independently and as part of a team;
- Effectively communicate complex concepts on scientific content and business processes in written or oral formats.
Workload
On-campus: 4-5 hours of contact per week, which will include a mix of presentations from industry experts and workshop activities. Off campus: a minimum of 7-8 hours of private study, including preparation of work for discussion and assessment.
| Activity | Duration |
|---|---|
| Workshops | 72 hours |
Ask about BMS5007
Answered from the Handbook fields above — no AI, no guessing. Every answer links back to the source.
Community discussions about BMS5007
CommunityStudent experience, not official rules. Nothing here changes what the Handbook says.